Reducing Systemic Inflammation in People on Antiretroviral Therapy

NCT07030920 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus (HIV)
Cardiovascular Risk Factor

Interventions

DRUG: Fostemsavir

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborators

[object Object]
[object Object]
[object Object]